Literature DB >> 17059789

Should we redefine hypertension?

Thomas D Giles1.   

Abstract

In the past, hypertension has been defined as a systemic arterial blood pressure chronically exceeding certain levels. However, it is now apparent that there is no blood pressure threshold that separates those with increased cardiovascular risk from those with no or low risk. Hypertension is a complex disease that eventually leads to an increase in blood pressure above optimal values for an individual. Moreover, levels of blood pressure, a physical force, need to be evaluated in the context of other cardiovascular risk factors. This definition of hypertension will permit physicians to treat patients with the goal of reducing global risk for myocardial infarction, stroke, and chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17059789     DOI: 10.1007/s11886-006-0095-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  16 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.

Authors:  Rod Jackson; Carlene M M Lawes; Derrick A Bennett; Richard J Milne; Anthony Rodgers
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

3.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.

Authors:  J D Neaton; D Wentworth
Journal:  Arch Intern Med       Date:  1992-01

4.  Blood pressure as a cardiovascular risk factor: prevention and treatment.

Authors:  W B Kannel
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

5.  Impact of high-normal blood pressure on the risk of cardiovascular disease.

Authors:  R S Vasan; M G Larson; E P Leip; J C Evans; C J O'Donnell; W B Kannel; D Levy
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

6.  The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.

Authors:  Mark J Sarnak; Tom Greene; Xuelei Wang; Gerald Beck; John W Kusek; Allan J Collins; Andrew S Levey
Journal:  Ann Intern Med       Date:  2005-03-01       Impact factor: 25.391

7.  The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem.

Authors:  Youfa Wang; Qiong Joanna Wang
Journal:  Arch Intern Med       Date:  2004-10-25

8.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

9.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

10.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.